EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433,446 | -14.6% | 127,484 | +84.6% | 0.00% | – |
| Q2 2023 | $507,540 | -36.2% | 69,053 | -10.1% | 0.00% | – |
| Q1 2023 | $795,378 | +69.3% | 76,774 | +93.0% | 0.00% | – |
| Q4 2022 | $469,884 | -28.4% | 39,787 | +27.3% | 0.00% | – |
| Q3 2022 | $656,000 | -32.9% | 31,261 | -0.6% | 0.00% | – |
| Q2 2022 | $977,000 | -24.5% | 31,450 | -0.3% | 0.00% | – |
| Q1 2022 | $1,294,000 | -96.0% | 31,532 | -95.8% | 0.00% | -100.0% |
| Q4 2021 | $32,492,000 | -4.2% | 747,470 | +10.4% | 0.00% | -33.3% |
| Q3 2021 | $33,913,000 | -21.5% | 677,322 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $43,199,000 | +82.6% | 685,799 | +169.3% | 0.00% | +50.0% |
| Q1 2021 | $23,660,000 | -40.5% | 254,651 | -42.6% | 0.00% | -50.0% |
| Q4 2020 | $39,736,000 | -12.3% | 443,484 | +1.1% | 0.00% | -20.0% |
| Q3 2020 | $45,308,000 | +183.1% | 438,473 | +116.6% | 0.01% | +150.0% |
| Q2 2020 | $16,006,000 | +533433.3% | 202,418 | +361360.7% | 0.00% | – |
| Q1 2020 | $3,000 | -100.0% | 56 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $15,661,000 | +125.6% | 290,281 | +118.6% | 0.00% | +100.0% |
| Q3 2019 | $6,943,000 | -60.5% | 132,800 | -63.5% | 0.00% | -50.0% |
| Q2 2019 | $17,599,000 | -32.1% | 364,299 | -29.0% | 0.00% | -33.3% |
| Q1 2019 | $25,931,000 | -15.6% | 513,281 | -1.0% | 0.00% | -25.0% |
| Q4 2018 | $30,727,000 | +11.4% | 518,345 | +23.7% | 0.00% | +33.3% |
| Q3 2018 | $27,594,000 | +88.1% | 419,175 | +44.3% | 0.00% | +50.0% |
| Q2 2018 | $14,668,000 | +180.7% | 290,507 | +192.7% | 0.00% | +100.0% |
| Q1 2018 | $5,226,000 | -9.2% | 99,259 | -19.8% | 0.00% | 0.0% |
| Q4 2017 | $5,754,000 | -11.3% | 123,822 | -22.8% | 0.00% | 0.0% |
| Q3 2017 | $6,490,000 | -12.5% | 160,447 | -26.6% | 0.00% | 0.0% |
| Q2 2017 | $7,416,000 | -11.6% | 218,701 | -24.3% | 0.00% | 0.0% |
| Q1 2017 | $8,388,000 | -11.4% | 288,830 | +0.2% | 0.00% | 0.0% |
| Q4 2016 | $9,469,000 | +45.5% | 288,348 | +39.7% | 0.00% | 0.0% |
| Q3 2016 | $6,509,000 | -54.1% | 206,450 | -59.1% | 0.00% | -50.0% |
| Q2 2016 | $14,179,000 | -28.1% | 504,247 | -7.1% | 0.00% | -33.3% |
| Q1 2016 | $19,729,000 | -10.0% | 542,741 | -0.9% | 0.00% | 0.0% |
| Q4 2015 | $21,917,000 | +39.2% | 547,783 | -0.9% | 0.00% | +50.0% |
| Q3 2015 | $15,748,000 | -13.0% | 552,741 | +0.6% | 0.00% | 0.0% |
| Q2 2015 | $18,097,000 | +15.2% | 549,241 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $15,710,000 | +6.6% | 546,241 | +0.9% | 0.00% | 0.0% |
| Q4 2014 | $14,743,000 | +21.0% | 541,441 | -5.3% | 0.00% | 0.0% |
| Q3 2014 | $12,184,000 | -6.8% | 571,741 | -1.7% | 0.00% | 0.0% |
| Q2 2014 | $13,068,000 | -13.9% | 581,813 | -3.1% | 0.00% | 0.0% |
| Q1 2014 | $15,171,000 | +54.1% | 600,362 | +40.2% | 0.00% | +100.0% |
| Q4 2013 | $9,845,000 | +48.6% | 428,225 | +23.1% | 0.00% | 0.0% |
| Q3 2013 | $6,627,000 | +17.8% | 347,884 | -10.8% | 0.00% | 0.0% |
| Q2 2013 | $5,627,000 | – | 390,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |